The US Breast Cancer Market

Market Research

The year 2022 initiated a big bang in the breast cancer segment. Did you know that more than 400,000 women patients live with breast cancer, with 43,250 female and 570 male patients? Breast cancer is a malignant cell growth in the breast tissue and can be caused by inherited genetic mutations of BRCA1 and BRCA2 genes, exposure to radiation, obesity, and other reasons. It impacts both males and females and is growing.

Key Points

  • The average risk of a woman in the United States developing breast cancer sometime in her life is about 13%.
  • Breast cancer survival rates are climbing as the diagnosis has increased, with the demand for precision medicine all-time high in the breast cancer drugs market.
  • The US breast cancer treatment market is a high opportunity segment fuelled by high competition and strong payer perception.
  • If breast cancer is localized, the survival rates can reach up to 99%.

To know more...


Related Topics

SG Analytics Healthcare Whitepaper - Orthodontics-Go or No Go APAC


“Go or No Go APAC” – Who wins the race after...

While businesses run on visibility, orthodontics in the dental industry is booming under the ‘invisible orthodontics’ sub-segment. The rise of...


New-Age Advertising Market Outlook

The global advertising industry has been consistently driving...

We bring comprehensive data driven insights to everyone, everywhere